Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?

Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?

Multiple myeloma (MM) is a good target disease in which one can apply cellular immunotherapy, which is based on the graft-versus-myeloma effect. This role of immune effector cells provides the framework for the development of immune-based therapeutic options that use antigen-presenting cells (APCs)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thanh-Nhan Nguyen-Pham, Yoon-Kyung Lee, Hyeoung-Joon Kim, Je-Jung Lee
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2012/397648
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells
by: My-Dung Hoang, et al.
Published: (2015-01-01)

Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells
by: Seo-Yeon Ahn, et al.
Published: (2025-10-01)

Immunotherapy for Multiple Myeloma
by: Nicolaus Kröger, et al.
Published: (2012-01-01)

Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
by: Min-Seon Song, et al.
Published: (2024-01-01)

Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential
by: Melanie Andrea Jordan, et al.
Published: (2025-04-01)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
by: Yi Lin, et al.
Published: (2020-10-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence
by: Wei-Chen Lee, et al.
Published: (2025-08-01)

Advances and perspective of the immunotherapy for relapsed/refractory multiple myeloma (interview)
by: S. V. Semochkin
Published: (2022-01-01)

The characteristics of Korean elderly multiple myeloma patients aged 80 years or over
by: Sang Hwan Lee, et al.
Published: (2025-01-01)

Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)
by: Jung Yeon Lee, et al.
Published: (2025-08-01)

Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes
by: Sergio Rutella, et al.
Published: (2012-01-01)

Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
by: Ivetta Danylesko, et al.
Published: (2012-01-01)

Deciphering the bone marrow microenvironment’s role in multiple myeloma immunotherapy resistance
by: Nicolas Thomas Iannozzi, et al.
Published: (2025-07-01)

Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
by: Oren Pasvolsky, et al.
Published: (2025-05-01)

Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
by: Danai Dima, et al.
Published: (2025-06-01)

Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis
by: Jinqiao Li, et al.
Published: (2024-12-01)

Immunotherapy in Multiple Myeloma: Recent Developments in Monoclonal Antibodies, Bispecifics and Antibody-Drug Conjugates
by: Rouven Müller
Published: (2024-12-01)

Multiple Myeloma in a Young Female Presenting with Neurological Symptoms
by: Matthew Lee, et al.
Published: (2020-01-01)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01)

Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01)

Ferroptosis: a novel pharmacological mechanism against multiple myeloma
by: Jingbo Shi, et al.
Published: (2025-07-01)

How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma
by: Wulyo Rajabto, et al.
Published: (2022-09-01)

P149: Testing of t(4;14) in multiple myeloma: How to do it
by: Ping Yang, et al.
Published: (2025-01-01)

The Multiple Myeloma
by: Keivan Daneshvar, et al.
Published: (2024-03-01)

Comprehensive machine learning analysis of PANoptosis signatures in multiple myeloma identifies prognostic and immunotherapy biomarkers
by: Yashu Feng, et al.
Published: (2025-07-01)

Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1
by: Ildefonso Sánchez-Cerrillo, et al.
Published: (2025-06-01)

IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)

Atypical Presentation of Multiple Myeloma: From Heart Failure to Multiple Myeloma
by: Ainur Elliana Sohaimi, et al.
Published: (2024-10-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma
by: Grace M. Ferri, et al.
Published: (2025-01-01)

Germline predisposition in multiple myeloma
by: Fernanda Martins Rodrigues, et al.
Published: (2025-01-01)

Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
by: Valerie R. Yanofsky, et al.
Published: (2013-01-01)

Optimal Control of Tumor Growth Model with Dendritic Cells as Immunotherapy
by: Firmansyah Reskal Motulo, et al.
Published: (2018-06-01)

Serum free light-chain concentration and relationship with some characteristics of patients with multiple myeloma
by: Van Nguyen-Thanh Phan, et al.
Published: (2023-01-01)

Laryngeal Involvement of Multiple Myeloma
by: Ariel B. Grobman, et al.
Published: (2012-01-01)

Multiple Myeloma of the Thyroid Cartilage
by: Peter Kalina, et al.
Published: (2012-01-01)

Spotlighting rising researcher Shannuo Li: MATCH: a flexible and safer approach to T cell–based immunotherapy for multiple myeloma
by: Shannuo Li
Published: (2025-08-01)

Metastatic Multiple Myeloma to the Skin
by: Alex C. Holliday, et al.
Published: (2019-01-01)

The role of Capon in multiple myeloma
by: Yaodong Shen, et al.
Published: (2017-06-01)